Cita APA

Vu, L., Cox, G. F., Ibrahim, J., Peterschmitt, M. J., Ross, L., Thibault, N., & Turpault, S. (2020). Effects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1. Mol Genet Metab Rep.

Chicago Style Citation

Vu, Lucie, Gerald F. Cox, Jennifer Ibrahim, M. Judith Peterschmitt, Leorah Ross, Nathan Thibault, i Sandrine Turpault. "Effects of Paroxetine, Ketoconazole, and Rifampin On the Metabolism of Eliglustat, an Oral Substrate Reduction Therapy for Gaucher Disease Type 1." Mol Genet Metab Rep 2020.

Cita MLA

Vu, Lucie, et al. "Effects of Paroxetine, Ketoconazole, and Rifampin On the Metabolism of Eliglustat, an Oral Substrate Reduction Therapy for Gaucher Disease Type 1." Mol Genet Metab Rep 2020.